The medical technology provider Carl Zeiss Meditec has reaffirmed its sales and margin targets for the current fiscal year 2011/12. Accordingly, the company aims to increase, on an annual basis, its total sales from EUR 830 to 860 million. It is also expected that in 2015 they will have an EBIT margin of 15%.
In the first nine months of 2011/12, Carl Zeiss Meditech increased sales by 13.6% to EUR 630.8 million and achieved an EBIT of EUR 88.6 million (previous year: EUR 75.7 million). The EBIT margin improved by 0.4 percentage points to 14.0 percent. Consolidated earnings climbed from EUR 48.9 to 52.8 million.
[ilink url=“http://www.finanznachrichten.de/nachrichten-2012-09/24675464-carl-zeiss-meditec-bekraeftigt-jahresziele-009.htm“] Link zur Quelle (Finanznachrichten.de )[/ilink]